122 related articles for article (PubMed ID: 33035538)
1. Paper 2. Epigallocatechin Gallate and Tannic Acid Based Formulations of Finasteride for Dermal Administration and Chemoembolization.
Jackson J; Schmitt V
J Pharm Sci; 2021 Feb; 110(2):807-814. PubMed ID: 33035538
[TBL] [Abstract][Full Text] [Related]
2. Part 1. Evaluation of Epigallocatechin Gallate or Tannic Acid Formulations of Hydrophobic Drugs for Enhanced Dermal and Bladder Uptake or for Local Anesthesia Effects.
Jackson J; Pandey R; Schmitt V
J Pharm Sci; 2021 Feb; 110(2):796-806. PubMed ID: 33039439
[TBL] [Abstract][Full Text] [Related]
3. The Effective Solubilization of Hydrophobic Drugs Using Epigallocatechin Gallate or Tannic Acid-Based Formulations.
Jackson JK; Letchford K
J Pharm Sci; 2016 Oct; 105(10):3143-3152. PubMed ID: 27522526
[TBL] [Abstract][Full Text] [Related]
4. In vitro study on anti-inflammatory effects of epigallocatechin-3-gallate-loaded nano- and microscale particles.
Wu YR; Choi HJ; Kang YG; Kim JK; Shin JW
Int J Nanomedicine; 2017; 12():7007-7013. PubMed ID: 29026297
[TBL] [Abstract][Full Text] [Related]
5. Microneedle-mediated intradermal delivery of epigallocatechin-3-gallate.
Puri A; Nguyen HX; Banga AK
Int J Cosmet Sci; 2016 Oct; 38(5):512-23. PubMed ID: 27009797
[TBL] [Abstract][Full Text] [Related]
6. Encapsulation of (-)-epigallocatechin gallate into liposomes and into alginate or chitosan microparticles reinforced with liposomes.
Istenič K; Cerc Korošec R; Poklar Ulrih N
J Sci Food Agric; 2016 Oct; 96(13):4623-32. PubMed ID: 26921243
[TBL] [Abstract][Full Text] [Related]
7. Photodegradation of (-)-epigallocatechin-3-gallate in topical cream formulations and its photostabilization.
Bianchi A; Marchetti N; Scalia S
J Pharm Biomed Anal; 2011 Dec; 56(4):692-7. PubMed ID: 21807473
[TBL] [Abstract][Full Text] [Related]
8. Effect of Polymeric Microparticles Loaded With Catechin on the Physicochemical Properties of an Adhesive System.
Albuquerque N; Neri JR; Lemos M; Yamauti M; de Sousa F; Santiago SL
Oper Dent; 2019; 44(4):E202-E211. PubMed ID: 30849016
[TBL] [Abstract][Full Text] [Related]
9. Exovascular application of epigallocatechin-3-O-gallate-releasing electrospun poly(L-lactide glycolic acid) fiber sheets to reduce intimal hyperplasia in injured abdominal aorta.
Lee MH; Kwon BJ; Koo MA; Jang EH; Seon GM; Park JC
Biomed Mater; 2015 Sep; 10(5):055010. PubMed ID: 26391656
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Bovine Serum Albumin and (-)-Epigallocatechin Gallate/3,4- O-Dicaffeoylquinic Acid/Tannic Acid Layer by Layer Assembled Microcapsule for Protecting Immunoglobulin G in Stomach Digestion and Release in Small Intestinal Tract.
Chen C; Chen G; Wan P; Chen D; Zhu T; Hu B; Sun Y; Zeng X
J Agric Food Chem; 2018 Oct; 66(42):11141-11150. PubMed ID: 30277397
[TBL] [Abstract][Full Text] [Related]
11. Development of (-)-epigallocatechin-3-gallate (EGCG)-loaded enteric microparticles with intestinal mucoadhesive property.
Onoue S; Ochi M; Yamada S
Int J Pharm; 2011 May; 410(1-2):111-3. PubMed ID: 21419204
[TBL] [Abstract][Full Text] [Related]
12. Transdermal solid delivery of epigallocatechin-3-gallate using self-double-emulsifying drug delivery system as vehicle: Formulation, evaluation and vesicle-skin interaction.
Hu C; Gu C; Fang Q; Wang Q; Xia Q
J Biomater Appl; 2016 Feb; 30(7):1080-91. PubMed ID: 26637442
[TBL] [Abstract][Full Text] [Related]
13. Enhancing skin penetration of epigallocatechin gallate by modifying partition coefficient using reverse micelle method.
Rosita N; Meitasari VA; Rianti MC; Hariyadi DM; Miatmoko A
Ther Deliv; 2019 Jul; 10(7):409-417. PubMed ID: 31319784
[No Abstract] [Full Text] [Related]
14. Human hair growth enhancement in vitro by green tea epigallocatechin-3-gallate (EGCG).
Kwon OS; Han JH; Yoo HG; Chung JH; Cho KH; Eun HC; Kim KH
Phytomedicine; 2007 Aug; 14(7-8):551-5. PubMed ID: 17092697
[TBL] [Abstract][Full Text] [Related]
15. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
Li H; Krstin S; Wink M
Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
[TBL] [Abstract][Full Text] [Related]
16. Finasteride Topical Delivery Systems for Androgenetic Alopecia.
Khan MZU; Khan SA; Ubaid M; Shah A; Kousar R; Murtaza G
Curr Drug Deliv; 2018; 15(8):1100-1111. PubMed ID: 29366416
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin Gallate-Loaded Gelatin-g-Poly(N-Isopropylacrylamide) as a New Ophthalmic Pharmaceutical Formulation for Topical Use in the Treatment of Dry Eye Syndrome.
Luo LJ; Lai JY
Sci Rep; 2017 Aug; 7(1):9380. PubMed ID: 28839279
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid/poly(lactic-co-glycolic acid) core/shell fiber meshes loaded with epigallocatechin-3-O-gallate as skin tissue engineering scaffolds.
Lee EJ; Lee JH; Jin L; Jin OS; Shin YC; Sang JO; Lee J; Hyon SH; Han DW
J Nanosci Nanotechnol; 2014 Nov; 14(11):8458-63. PubMed ID: 25958546
[TBL] [Abstract][Full Text] [Related]
19. In vivo human skin penetration of (-)-epigallocatechin-3-gallate from topical formulations.
Scalia S; Trotta V; Bianchi A
Acta Pharm; 2014 Jun; 64(2):257-65. PubMed ID: 24914725
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, structure analyses, and characterization of novel epigallocatechin gallate (EGCG) glycosides using the glucansucrase from Leuconostoc mesenteroides B-1299CB.
Moon YH; Lee JH; Ahn JS; Nam SH; Oh DK; Park DH; Chung HJ; Kang S; Day DF; Kim D
J Agric Food Chem; 2006 Feb; 54(4):1230-7. PubMed ID: 16478241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
